A phase II investigation of pentostatin in metastatic malignant melanoma

Invest New Drugs. 1992 Nov;10(4):345-6. doi: 10.1007/BF00944193.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Humans
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Middle Aged
  • Pentostatin / therapeutic use*

Substances

  • Pentostatin